Utilizing Plasma Circulating Tumor DNA Sequencing for Precision Medicine in the Management of Solid Cancers

Plasma circulating tumor DNA (ctDNA) sequencing has demonstrated clinical utility for tumor molecular profiling at initial diagnosis or tumor progression in advanced solid cancers and is being rapidly incorporated into the clinical practice guidelines, including non–small cell lung and breast cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Cha, Yongjun, Kim, Sheehyun, Han, Sae-Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101775/
https://www.ncbi.nlm.nih.gov/pubmed/36915241
http://dx.doi.org/10.4143/crt.2023.446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101775/
https://www.ncbi.nlm.nih.gov/pubmed/36915241
http://dx.doi.org/10.4143/crt.2023.446

Ejemplares similares